Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB09017_nanopub.RA9O9Bu1q9OB76x_--nQFP35X9rdFiN0RwFMCDCWaT8DY#assertion>. }
Showing items 1 to 15 of
15
with 100 items per page.
- drugbank:DB09017 type drugbank_vocabulary:Drug assertion.
- drugbank:DB09017 label "Brotizolam [drugbank:DB09017]" assertion.
- drugbank:DB09017 seeAlso brotizolam.html assertion.
- drugbank:DB09017 seeAlso DB09017 assertion.
- drugbank:DB09017 description "Brotizolam is a sedative-hypnotic thienodiazepine drug which is a benzodiazepine analog. It possesses anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties, and is considered to be similar in effect to short-acting benzodiazepines such as triazolam. It is used in the short term treatment of severe or debilitating insomnia. Brotizolam is an extremely potent drug and it is rapidly eliminated with an average half-life of 4.4 hours (range 3.6 - 7.9 hours). Brotizolam is not approved for sale in the UK, United States or Canada. It is approved for sale in the Netherlands, Germany, Spain, Belgium, Austria, Portugal, Israel, Italy and Japan." assertion.
- drugbank:DB09017 identifier "drugbank:DB09017" assertion.
- drugbank:DB09017 title "Brotizolam" assertion.
- drugbank:DB09017 drugbank_vocabulary:x-cas cas:57801-81-7 assertion.
- drugbank:DB09017 drugbank_vocabulary:drugbank-id "DB09017" assertion.
- drugbank:DB09017 bio2rdf_vocabulary:x-identifiers.org DB09017 assertion.
- drugbank:DB09017 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB09017" assertion.
- drugbank:DB09017 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB09017 bio2rdf_vocabulary:identifier "DB09017" assertion.
- drugbank:DB09017 drugbank_vocabulary:x-wikipedia wikipedia:Brotizolam assertion.
- drugbank:DB09017 drugbank_vocabulary:x-kegg kegg:D01744 assertion.